chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 6.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Urticaria
Clinical narrative: Mother reports child reporting itching as soon as she got into car. Went to PCP. Dx Allergic urticaria - Given prednisolone PO and BENADRYL PO.
Age: 1.01
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Injection site cellulitis, Injection site erythema, Injection site mass, Vaccination site pain, Vaccination site swelling
Clinical narrative: Cellulitis of left thigh diagnosed 1-6-14 per mom red lump at vaccine site for 5 days. Swollen, tender. Febrile x 4-5 days.
Age: 15.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Pain, Pruritus
Clinical narrative: 5 cm injection site reaction. Swelling, redness, warm to the touch. Client reports pain and itching.
Age: 11.0
Sex: M
Vaccine: FLU3, MNQ, TDAP
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: (L) deltoid erythematous area approximately 4cm x 3cm with pain. No other s/sx. Outlined area return if worse or not improving. Erythema and pain tx with ibuprofen and cool compress.
Age: 11.0
Sex: F
Vaccine: MEN, TDAP
Symptoms: Rash macular
Clinical narrative: Blotchy rash appeared on arm within an hour of injection, BENADRYL/antihistamine and TYLENOL given immediately. It took about 2 days for it to away completely.
Age: 24.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Blood pressure decreased, Feeling cold, Gaze palsy, Hyperhidrosis, Loss of consciousness
Clinical narrative: After the shot pt was passing out. Very sweaty and cold. Eyes got rolled over. Called 911. They said the blood pressure has dropped and recommended to take her to hospital which pt denied.
Age: 24.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Blood pressure decreased, Eye movement disorder, Feeling cold, Hyperhidrosis, Loss of consciousness
Clinical narrative: After the shot pt was passing out. Very sweaty and cold. Eyes got rolled over. Called 911. They said the blood pressure has dropped and recommended to take her to hospital which pt denied.
Sex: M
Vaccine: DTAP
Symptoms: Anaphylactic reaction, Respiratory arrest
Clinical narrative: This case was reported by a pharmacist and described the occurrence of anaphylactic reaction in a male subject of unspecified age who was vaccinated with DTPa (with small D and P), manufacturer unspecified). On an unspecified date the subject received a dose of DTPa (with small D and P) (unknown details). The vaccination was administered "many years ago." Per the pharmacist, the subject was not sure if he received the BOOSTRIX or "it might have been similar vaccine from another manufacturer." At an unspecified time after vaccinations with DTPa (with small D and P), the subject experienced anaphylactic reaction and stopped breathing. The pharmacist reported that the subject "was probably hospitalized due to the anaphylactic reaction." This case was assessed as medically serious by GSK. At the time of reporting the events were resolved. No additional details were provided.
Age: 40.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Chest pain, Dizziness, Nausea, Pain, Retching
Clinical narrative: I experienced the usual achiness post flu shot which was of no concern. In addition, I experienced significant chest pain, sensations of food being stuck in my throat, gagging with and without food or beverage being consumed, frequent and extreme nausea and dizziness.
Age: 40.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Sensation of foreign body
Clinical narrative: I experienced the usual achiness post flu shot which was of no concern. In addition, I experienced significant chest pain, sensations of food being stuck in my throat, gagging with and without food or beverage being consumed, frequent and extreme nausea and dizziness.
Age: 65.0
Sex: F
Vaccine: FLUX
Symptoms: Abdominal pain upper, Dizziness, Headache, Lethargy, Myalgia
Clinical narrative: Vomiting, Dizziness, Headache, Muscle Ache, Stomach Ache Took 2 Tums antacid and went to bed. Woke up feeling dizzy, headache, muscle aches, lethargic, face swelling.
Age: 65.0
Sex: F
Vaccine: FLUX
Symptoms: Swelling face, Vomiting
Clinical narrative: Vomiting, Dizziness, Headache, Muscle Ache, Stomach Ache Took 2 Tums antacid and went to bed. Woke up feeling dizzy, headache, muscle aches, lethargic, face swelling.
Age: 36.0
Sex: F
Vaccine: FLUX, TD
Symptoms: Fatigue, Lacrimation increased, Malaise, Sneezing
Clinical narrative: Malaise, fatigue, sneezing, watery eyes.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness and swelling the size of silver dollar at injection site.
Age: 42.0
Sex: F
Vaccine: TDAP
Symptoms: Discomfort, Induration
Clinical narrative: Patient c/o firmness and discomfort.
Age: 30.0
Sex: F
Vaccine: PPV
Symptoms: Blood culture, Incisional drainage, Joint range of motion decreased, Pain, Pyrexia
Clinical narrative: Information was received from medical records from a case in litigation (MARRS#1307USA014180) regarding a 30 year old female. The patient was hospitalized on 04-SEP-2012 for PE (MARRS# 1307USA014180). It was noted that she recently received a "pneumonia shot" (manufacturer not specified), date was not specified. The patient reported that she had experienced restrictive range of motion, pain and swelling. The patient spiked a fever and infectious disease was consulted. An incision and drainage was done in the right upper arm, anterior deltoid area. Blood cultures were drawn. The patient was started on empiric vancomycin and her right arm was elevated. The swelling and pain subsequently improved within 24 hours and the patient was changed to oral doxycycline. The patient was discharged from hospital on 09-SEP-2012 when her PE and blood clot was noted to be resolving. All available medical records will be provided upon request. Additional information is not expected.
Age: 30.0
Sex: F
Vaccine: PPV
Symptoms: Swelling, Thrombosis
Clinical narrative: Information was received from medical records from a case in litigation (MARRS#1307USA014180) regarding a 30 year old female. The patient was hospitalized on 04-SEP-2012 for PE (MARRS# 1307USA014180). It was noted that she recently received a "pneumonia shot" (manufacturer not specified), date was not specified. The patient reported that she had experienced restrictive range of motion, pain and swelling. The patient spiked a fever and infectious disease was consulted. An incision and drainage was done in the right upper arm, anterior deltoid area. Blood cultures were drawn. The patient was started on empiric vancomycin and her right arm was elevated. The swelling and pain subsequently improved within 24 hours and the patient was changed to oral doxycycline. The patient was discharged from hospital on 09-SEP-2012 when her PE and blood clot was noted to be resolving. All available medical records will be provided upon request. Additional information is not expected.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, FLU3, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: MOTHER NOTED THIS AM REDNESS AND SLIGHT SWELLING OF CHILD'S RIGHT DELTOID AREA.  NO FEVER OR ANY OTHER COMPLAINTS REPORTED FROM PARENT.
Age: 35.0
Sex: M
Vaccine: ANTH
Symptoms: Pain, Pruritus, Skin exfoliation
Clinical narrative: In 2002 he received the first two of 8 doses of anthrax vaccine. Two weeks after one of them he developed a pruritic, scaly patch about 3 inches in diameter below his right axilla. It persisted about a year and never returned. However, this year he developed a severe, painful, pruritic condition of his extremities and wondered if the pruritic patch in 2002 was related. He had a previous history of the painful/pruritic condition before the anthrax immunization, but not severe and only every few years. The place where he received the immunizations is not known.
Age: 8.0
Sex: F
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: Temp 97.7 pt was given Flu vaccine at 2:13 PM at approx 2:20 PM pt had developed hives to face and arms. No difficulty breathing 911 called and taken to ER.
Age: 1.39
Sex: M
Vaccine: DTAP, HIBV, MMR
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: Received DTaP immun in (R) thigh on 1/14/14. Mom noticed erythema and swelling in PM on 1/15/14, increasing size, (+) warm to touch. No fever.
Age: 4.0
Sex: M
Vaccine: DTAP, MMR
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus, Injection site warmth
Clinical narrative: Patient's mother noticed that the (L) arm of the child was sore on 1-15-14 in the am. Then during the PM that night she noticed it was hard, red and hot. He complained that it itched and hurted.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site warmth
Clinical narrative: Large area of redness-about 6"x4" (spreading), area is warm to the touch, rash at onset, itching 4 days after injection.
Age: 45.0
Sex: F
Vaccine: FLU4, PPV, TDAP
Symptoms: Convulsion, Disorientation, Intensive care
Clinical narrative: Received call on 01/13/2014 from niece inquiring as to vaccines received by client. Stated client was hospitalized after she became disoriented on 01/08/2014 and developed seizures which have been uncontrollable. Remains in ICU (stable).
Age: 19.0
Sex: F
Vaccine: HEPA, TYP, YF
Symptoms: Pharyngeal oedema
Clinical narrative: Pt tried to stay awake as she was worried. Did not call office or on call provider, did not take Benadryl. Fell asleep around 1 AM. Symptoms resolved when she awoke.  Called us 12/19/2013 to report the incident.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Cough, Eye swelling, Ocular hyperaemia, Oropharyngeal pain
Clinical narrative: Fever, chills, body aches, sore throat, cough, somewhat constricted throat, swollen upper and lower eye area, red eyes.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Pain, Pyrexia, Throat tightness
Clinical narrative: Fever, chills, body aches, sore throat, cough, somewhat constricted throat, swollen upper and lower eye area, red eyes.
Age: 59.0
Sex: F
Vaccine: FLUX
Symptoms: Borrelia test, CSF test, Hypoaesthesia, Nuclear magnetic resonance imaging brain, Paraesthesia
Clinical narrative: Tingling in fingers, toes, tongue, and bilateral legs.
Age: 59.0
Sex: F
Vaccine: FLUX
Symptoms: Paraesthesia oral, Vitamin B12
Clinical narrative: Tingling in fingers, toes, tongue, and bilateral legs.
Age: 56.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: VIIth nerve paralysis
Clinical narrative: Patient claimed that the Bell's palsy on the right side of his face appeared on the morning for 1/13/14 when he woke up. He assumed that it was from the flu vaccine that he got from the pharmacy. He reported it to us on 1/17/14.
Age: 28.0
Sex: M
Vaccine: PPV
Symptoms: Death, Dyskinesia, Guillain-Barre syndrome, Hypoaesthesia, Pain
Clinical narrative: Numbness in toes, ascending numbness to hip level. Shooting pains from toes to hips. Numbness of fingers moving up forearms and hands. Loss of muscle control in legs. Slow onset of numbness and pain in toes in late August. Rapid progression up to hips, arms and hands in late September. Treated in hospital for Guillain Barre 10/02/2012 to 10/07/2012. Has not fully recovered.
Age: 28.0
Sex: M
Vaccine: PPV
Symptoms: Pain in extremity, Pneumonia
Clinical narrative: Numbness in toes, ascending numbness to hip level. Shooting pains from toes to hips. Numbness of fingers moving up forearms and hands. Loss of muscle control in legs. Slow onset of numbness and pain in toes in late August. Rapid progression up to hips, arms and hands in late September. Treated in hospital for Guillain Barre 10/02/2012 to 10/07/2012. Has not fully recovered.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Blood glucose normal, Computerised tomogram normal, Concussion, Fall, Head injury
Clinical narrative: While in a store with mom ? syncope OR ? slipped and fell hitting his head. Later started vomiting, was sleepy and difficult to awaken. Seen at Emergency Room. Concussion follow-up with our office on 11/15/13. On 11/20/13 was seen in ER for altered mental state. Follow-up with our office on 11/27/13. Referred to Neurology, consult pending.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Mental status changes, Somnolence, Vomiting
Clinical narrative: While in a store with mom ? syncope OR ? slipped and fell hitting his head. Later started vomiting, was sleepy and difficult to awaken. Seen at Emergency Room. Concussion follow-up with our office on 11/15/13. On 11/20/13 was seen in ER for altered mental state. Follow-up with our office on 11/27/13. Referred to Neurology, consult pending.
Age: 29.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Lymph node pain, Lymphadenopathy
Clinical narrative: 1/13/2014-PAIN, SWELLING AND REDNESS AT INJECTION SIGHT. 1/13/2014-1/17/2014- PAIN PERSISTS DOWN ARM EVEN WITH DAILY MODERATE EXERCISE AND MASSAGE. 1/17/2014- 4:00 PM SWOLLEN LYMPH NODE PAINFUL AND GROWING. CONTACTED DRS OFFICE TO INQUIRE ABOUT APPROPRIATE ACTIONS TO TAKE.
Age: 60.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Rash
Clinical narrative: Rash.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Middle insomnia, Mobility decreased, Pain
Clinical narrative: Pt could not lift arm above head. Pain would wake her up at night. Reported to rx on 11/18/13.
Age: 34.0
Sex: M
Vaccine: PPV, TDAP, YF
Symptoms: Injection site erythema, Injection site pain, Pyrexia
Clinical narrative: Pt. returned to clinic 1/16/14 with redness, pain at injection site and temp of 100. Given KEFLEX. 1/17/14 Returned to clinic w/ increasing redness, pain and report of fever last night. Given Rx for BACTRIM. ROCEPHIN 500mg IM.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Cellulitis
Clinical narrative: Patient claims cellulitis.
Age: 18.0
Sex: U
Vaccine: VARCEL
Symptoms: Rash papular, Rash vesicular
Clinical narrative: Onset papular rash 2 wks after vaccine discrete lesions, 1 vesicular - dx atypical varicella secondary vaccine. Tx BENADRYL.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Swollen raised tender area around vaccination spot. (Larger than presumed normal). Quite big (3 inches long 1 inch wide).
Age: 40.0
Sex: F
Vaccine: FLU3, TDAP, FLU3, TDAP
Symptoms: Dizziness, Dyspnoea, Hypertension, Local swelling
Clinical narrative: The patient visited the emergency room the day after vaccines were administered with complaints of shortness of breath, dizziness, high blood pressure, and a swollen arm (right arm).
Age: 16.0
Sex: F
Vaccine: FLU3, HEPA, HPV4, MNQ, FLU3, HEPA, HPV4, MNQ
Symptoms: Loss of consciousness, Posture abnormal
Clinical narrative: pt was here for well child, pt in need of booster vaccines, pt was given vaccine questionnaire and completed the only yes was FLUMIST from last year. Dr examined pt and advised vaccinations. Upon doing the vaccines, after doing the last vaccine the patient passed out, she slid sideways on the table but did not hit floor. Patient did not lose LOC, Dr was advised she examined the pt., pt was monitored for 1 hour in the office, patient sent home with no side effects.
Age: 16.0
Sex: F
Vaccine: FLU3, HEPA, HPV4, MNQ, FLU3, HEPA, HPV4, MNQ
Symptoms: Fall, Loss of consciousness
Clinical narrative: pt was here for well child, pt in need of booster vaccines, pt was given vaccine questionnaire and completed the only yes was FLUMIST from last year. Dr examined pt and advised vaccinations. Upon doing the vaccines, after doing the last vaccine the patient passed out, she slid sideways on the table but did not hit floor. Patient did not lose LOC, Dr was advised she examined the pt., pt was monitored for 1 hour in the office, patient sent home with no side effects.
Age: 42.0
Sex: F
Vaccine: TYP, YF
Symptoms: Headache
Clinical narrative: Pt. started oral typhoid at approx 10 pm 1-14-14 woke up 1-15-14 with headache. Took second pill with large amt water approx 8:30 pm 1-16-14. Headache worse today 1-17-14. Taken to doctor for shot of morphine. Given Rx - hydrocodone every 4 hrs. which has helped.
Sex: U
Vaccine: HPV4, HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from a certified medical assistant (CMA) regarding a patient of an unknown age and gender who on 25-JUL-2013 and 22-OCT-2013 was vaccinated with an improperly stored dose of GARDASIL exposed of 20F and 30 F. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: HPV4, HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from a certified medical assistant (CMA) regarding a patient of unknown age and gender who on 30-JUL-2013 was vaccinated with an improperly stored dose of GARDASIL exposed to 20F and 30 F. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report as receive from a physician refers to a patient of unknown age and gender. Medical history and concurrent condition were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX (dose, route, lot number and expiration date were not provided). Secondary and concomitant therapies were not reported. On an unknown date, a patient received expired ZOSTAVAX recently that was about 3 months out of date. No adverse event reported. Additional information has been requested.
Age: 57.0
Sex: M
Vaccine: VARZOS
Symptoms: Feeling hot, Injection site erythema, Injection site inflammation, Injection site pain, Pain in extremity
Clinical narrative: This spontaneous report as received from a pharmacist and the patient refers to a 57 year old male patient. Patient with allergic reaction to penicillin. No pertinent medical history was reported. On 11-JAN-2014 the patient was vaccinated with ZOSTAVAX (dose, lot number and expiration date not reported) subcutaneously (the patient thought). There was no concomitant medication reported. The patient reported that he was having a reaction to the ZOSTAVAX shot. On 12-JAN-2014, one day after getting the vaccine, his left arm (site of the injection) was sore. On 13-JAN-2014 two days after getting the shot, his arm was sorer and getting worse with each hour. His arm felt very hot and he had a red circle around the injection site and that had gotten bigger each day and a second red circle had appeared near the injection site. The pharmacist reported that the patient had inflammation, redness and pain at the injection site where he received ZOSTAVAX that was spreading on his arm and was not getting better. The patient sought for medical attention and talked to the pharmacist. No treatment was given for the events. The outcomes of the events were reported as not recovered. Additional information has been requested.
Age: 1.02
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Irritability, Lacrimation increased, Pyrexia, Rash maculo-papular
Clinical narrative: Child developed fever 101 on day 2 and 3 after vaccinations, papulomacular rash on day 3 on the face, day 4 on the trunk, teary eyes with minimal discharge on day 3. Pt was seen first time after immunizations on day 5 - no fever, rash on the face, trunk and extremities, cranky.
Age: 34.0
Sex: F
Vaccine: HPV4
Symptoms: Colonoscopy, Loss of consciousness, Malaise, Papilloma viral infection, Smear cervix abnormal
Clinical narrative: This report from study was received from a 34 year old female patient referring on herself with postural hypotension and no drug reactions/allergies. Approximately in 2001, the patient participated in a study that began in one place and ended in another, and was vaccinated with GARDASIL (Dose, route, and lot number were not reported). After the study, the patient learned she had been given the placebo and then later after her son was born, in approximately 2007, she received the actual GARDASIL (dose, route and lot number were not reported). No co-suspect therapies were reported. There was no concomitant medication. The patient stated that during the study she passed out after one of the GARDASIL doses but she does not know if it was a placebo dose or one of the doses related to the GARDASIL product dose. The patient also stated she often did not feel well after receiving the GARDASIL doses (again she did not know if they were the placebo or the actual product dose). The patient had questions about the efficacy of GARDASIL because she was recently, about six months ago (approximately in August 2013) diagnosed with HPV type 16 even though she was vaccinated against it. At the time of this report the outcome was unknown. No treatment was given for the adverse events. Papanicolaou (PAP) smear and colonoscopy was performed. The patient sought medical attention. Upon internal review the event passed out was considered as an other important medical event. The causality was not reported. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from a certified medical assistant (CMA) regarding a patient of an unknown age and gender who on 16-SEP-2013 and 30-NOV-2013 was vaccinated with an improperly stored dose of GARDASIL exposed to 20F and 30 F. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Age: 34.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: This spontaneous report was received from a currently 34 year old female consumer regarding herself. On unspecified date in 1999 (also reported as "15 years ago") the patient was vaccinated with the first dose of VARIVAX (Merck) (dose, lot, and route were not reported) for vaccination. On unspecified date in 2012 (also reported as "2 years ago") the patient was vaccinated with the second dose of VARIVAX (Merck) (dose, duration and indication were not reported). On unknown date, the patient performed lab diagnostics studies included varicella antibody titers with negative titers to varicella. On unknown date, the patient sought medical attention in the office visit. On 16-DEC-2013 (also reported "4 weeks ago"), patient found that had negative antibody titers to varicella. The outcome of negative antibody titers to varicella and administered one dose of VARIVAX 15 years ago and a second dose of VARIVAX 2 years ago was unknown. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from a certified medical assistant (CMA) regarding a patient of an unknown age and gender who on 26-SEP-2013 was vaccinated with an improperly stored dose of GARDASIL exposed to 20F and 30 F. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Age: 8.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site rash, Injection site swelling
Clinical narrative: A 3 inch area around injection site is very swollen, reddish and has a rash.  Was given diphenhydramine HCI 25mg at 11:00 pm.
Age: 11.0
Sex: M
Vaccine: FLUX, MNQ, TDAP
Symptoms: Guillain-Barre syndrome, Muscular weakness, Nuclear magnetic resonance imaging abnormal, Pain in extremity
Clinical narrative: Limbs pain and weakness.  Diagnosed with GBS on 1/8/14 by neurologist.
Age: 9.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site swelling
Clinical narrative: Swelling of injected deltoid to twice normal size as reported by mother over the phone.
Age: 52.0
Sex: M
Vaccine: DTP, PPV
Symptoms: Bacterial infection, Cystitis, Influenza, Lower respiratory tract infection, Nasopharyngitis
Clinical narrative: 8/30: herpes outbreak on lip, 10/3: corneal herpes activated, 10/12: bladder infection, 10/17-22 bacterial infection of intestines, 11/12-11/23: severe flu, 12/16-1/18 flu/cold w\ chest infection. 1/4/2014: bladder infection.
Age: 52.0
Sex: M
Vaccine: DTP, PPV
Symptoms: Ophthalmic herpes simplex, Oral herpes
Clinical narrative: 8/30: herpes outbreak on lip, 10/3: corneal herpes activated, 10/12: bladder infection, 10/17-22 bacterial infection of intestines, 11/12-11/23: severe flu, 12/16-1/18 flu/cold w\ chest infection. 1/4/2014: bladder infection.
Age: 5.0
Sex: M
Vaccine: FLUX
Symptoms: Injection site erythema, Injection site oedema, Injection site swelling, Injection site warmth
Clinical narrative: Edematous swollen hot arm with surrounding erythema at the site 10 x 6 cm in size. Currently being treated with Keflex, topical steroids and acetic acid wet compresses.
Age: 0.74
Sex: M
Vaccine: DTAP, FLU3, IPV, PNC13
Symptoms: Blood culture, Pyrexia, Rash, Rash erythematous, Skin lesion
Clinical narrative: An erythematous rash started on trunk area and gradually spread to face and extremities over a period of three days.  The rash included marked erythema with red, raised target lesions of various sizes. There was no parities.  The episode lasted for approximately 4-5 days before improvement was noted with decreasing intensity of the rash.  Fever of 101 - 102 was present for the first 2 days.  The patient was never in any distress.  There was no clinical response to antihistamines or corticosteriods.
Age: 59.0
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Dyspnoea, Endotracheal intubation, Pulmonary haemorrhage, Renal haemorrhage
Clinical narrative: PM Nov 13 onset shortness of breath; pulmonary hemorrhage; diagnosed Nov 18; intubated Nov 20; renal hemorrhage.
Age: 26.0
Sex: F
Vaccine: HEPA, HPV4
Symptoms: Arthralgia, Headache, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Soreness and swelling at injection site within hours of injection. by 1/18/2014 at 0400, patient was experiencing joint pain, nausea, sharp headaches, body aches and photosensitivity. Patient self-treated with ibuprofen and additional rest with minimal improvement by 4:00pm 1/18/14. Tenderness, redness and mild swelling at injection site continues.
Age: 26.0
Sex: F
Vaccine: HEPA, HPV4
Symptoms: Nausea, Pain, Photosensitivity reaction
Clinical narrative: Soreness and swelling at injection site within hours of injection. by 1/18/2014 at 0400, patient was experiencing joint pain, nausea, sharp headaches, body aches and photosensitivity. Patient self-treated with ibuprofen and additional rest with minimal improvement by 4:00pm 1/18/14. Tenderness, redness and mild swelling at injection site continues.
Age: 0.54
Sex: F
Vaccine: VARCEL
Symptoms: Injection site reaction, Varicella post vaccine
Clinical narrative: Chicken pox rash on butt and leg that received the chicken pox shot. Mom also received minor case of chicken pox from touching the rash. Symptoms from shot showed up ten days after shot. Looked really bad for about eight days. Still there slightly.
Age: 65.0
Sex: F
Vaccine: FLU4
Symptoms: Erythema, Local swelling, Mobility decreased, Pain in extremity, Skin warm
Clinical narrative: Severe swelling & pain/ pain severe enough that arm could not be touched/ patient could not lift arm/ swelling spread over an area of 3 1/2 inches by 2 inches/ redness over same area and the area warm to the touch.
Age: 1.03
Sex: M
Vaccine: FLUX, HEPAB, MMR, VARCEL
Symptoms: Blood test, Chest X-ray, Convulsion, Febrile convulsion, Pyrexia
Clinical narrative: Febrile seizure that lasted 10 minutes long. Fever of 104.7. Seizure happend at 1:00 AM.
Age: 1.03
Sex: M
Vaccine: FLUX, HEPAB, MMR, VARCEL
Symptoms: Urine analysis
Clinical narrative: Febrile seizure that lasted 10 minutes long. Fever of 104.7. Seizure happend at 1:00 AM.
Age: 11.0
Sex: F
Vaccine: FLU3, HPV4, MNQ, TDAP
Symptoms: Dizziness, Hypertonia, Injection site anaesthesia, Syncope
Clinical narrative: Pt had MCV4 and Tdap on LA was ok. Flu vac. and HPV on her RA. After the HPV vaccine c/o of numbness on Rt shoulder. Then fainted rt after, 1-2 min tonic movement O2 given after O2 100%. Partially still dizzy, went to ER for further evaluation.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug
Clinical narrative: Information has been received from the nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had administered a dose of GARDASIL on 01-APR-2013 (lot # H011350, Expiration Date: 21-FEB-2015). This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 29-MAR-2013 (lot # H011350, Expiration Date: 21-FEB-2015). No adverse event was reported. This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had administered a dose of GARDASIL on 17-APR-2013 (lot # H011350, Expiration Date: 21-FEB-2015). No adverse event was reported. This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 22-APR-2013 (lot # H011350, Expiration Date: 21-FEB-2015). No adverse event reported. This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 26-APR-2013 (lot # H011350, Expiration Date: 21-FEB-2015). No adverse event was reported. This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL was stored in improper temperatures and were administered to overall number of 132 patients. The report refers to one of the patients involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 29-APR-2013 (lot # H011350, Expiration Date: 21-FEB-2015). No adverse event was reported. This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the registered nurse. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who on 11-DEC-2012 had administered dose of GARDASIL (lot # 670048/0963AA expiration date 09-NOV-2013) that was exposed to temperature of 11 Celsius degree. No adverse effects were reported. This is one of the report from the same source. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug
Clinical narrative: Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patient's involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 06-MAY-2013 (lot # H011350, Expiration Date: 21-FEB-2015). This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug
Clinical narrative: Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL were stored in improper temperatures and were administered to overall number of 101 patients. This report refers to one of the patient's involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 26-JUN-2013 (lot # H021608, Expiration Date: 13-AUG-2015). This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the registered nurse. It was reported that GARDASIL were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who on 18-DEC-2012 had administered dose of GARDASIL (lot # 670048/0963AA expiration date 09-NOV-2013) that was exposed to temperature of 11 Celsius degree. No adverse effects were reported. This is one of the report from the same source. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug
Clinical narrative: Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperatures and administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 28-JUN-2013 (lot # H021608, Expiration Date: 13-AUG-2015). This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug
Clinical narrative: Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperatures and administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 01-JUL-2013 (lot # H010915, Expiration Date: 13-FEB-2015). This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the registered nurse. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who on 09-JAN-2013 had administered dose of GARDASIL (lot # H011350 expiration date 21-FEB-2015) that was exposed to temperature of 11 Celsius degree. No adverse effects were reported. This is one of the report from the same source. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the registered nurse. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who on 10-JAN-2013 had administered dose of GARDASIL (lot # 0131AE expiration date 26-OCT-2014) that was exposed to temperature of 11 Celsius degree. No adverse effects were reported. This is one of the report from the same source. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patient's involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 29-APR-2013 (lot # H011350, Expiration Date: 21-FEB-2015). No adverse event was reported. This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the registered nurse. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who on 15-JAN-2013 had administered dose of GARDASIL (lot # H011350 expiration date 21-FEB-2015) that was exposed to temperature of 11 Celsius degree. No adverse effects were reported. This is one of the several reports from the same source. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug
Clinical narrative: Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patient's involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 10-JUL-2013 (lot # H010915, Expiration Date: 13-FEB-2015). This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the registered nurse. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who on 22-MAR-2013 was administered a dose of GARDASIL (lot # H011350 and expiration date 21-FEB-2015) that was exposed to temperature of 11 Celsius degree. No adverse effects were reported. This is one of several reports from the same source. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the registered nurse. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who on 20-MAR-2013 was administered a dose of GARDASIL (lot # and expiration date were not reported) that was exposed to temperature of 11 Celsius degree. No adverse effects were reported. This is one of several reports from the same source. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the registered nurse. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who on 18-MAR-2013 was administered a dose of GARDASIL (lot # and expiration date were not reported) that was exposed to temperature of 11 Celsius degree. No adverse effects were reported. This is one of several reports from the same source. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug
Clinical narrative: Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperatures and administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 06-AUG-2013 (lot # H021608, exp.: 13-AUG-2015). This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the registered nurse. It was reported that GARDASIL were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who on 18-MAR-2013 was administered a dose of GARDASIL (lot # and expiration date were not reported) that was exposed to temperature of 11 Celsius degree. No adverse effects were reported. This is one of several reports from the same source. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the registered nurse. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who on 11-MAR-2013 was administered a dose of GARDASIL (lot # H011350 and expiration date 21-FEB-2015) that was exposed to temperature of 11 Celsius degree. No adverse effects were reported. This is one of several reports from the same source. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug
Clinical narrative: Information has been received from the registered nurse on 02-JAN-2014. It was reported th at GARDASIL vaccines were stored in improper temperatures and administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 29-JUL-2013 (lot # H021608, exp.: 13-AUG-2015). This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the registered nurse. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who on 26-FEB-2013 was administered a dose of GARDASIL (lot # H011350 and expiration date 21-FEB-2015) that was exposed to temperature of 11 Celsius degree. No adverse effects were reported. This is one of several reports from the same source. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug
Clinical narrative: Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patient's involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 29-JUL-2013 (lot # H021608, Expiration Date: 13-AUG-2015). This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the registered nurse. It was reported that GARDASIL were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who on 21-FEB-2013 was administered a dose of GARDASIL (lot # 668261/1397AA and expiration date 09-APR-2013) that was exposed to temperature of 11 Celsius degree. No adverse effects were reported. This is one of several reports from the same source. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug
Clinical narrative: Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 09-AUG-2013 (lot # and exp. date not reported). This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug
Clinical narrative: Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperatures and administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 20-AUG-2013 (lot # H021608, exp.: 13-AUG-2015). This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug
Clinical narrative: Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperatures and administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 29-AUG-2013 (lot # H021608, exp: 13-AUG-2015). This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information has been received from the registered nurse. It was reported that GARDASIL were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who on 28-JAN-2013 was administered a dose of GARDASIL (lot # H011350 expiration date 21-FEB-2015) that was exposed to temperature of 11 Celsius degree. No adverse effects were reported. This is one of the several reports from the same source. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug
Clinical narrative: Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperatures and administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 15-JUL-2013 (lot # H010915, Expiration Date: 13-FEB-2015). This is one of the report from the same source, linked reports. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug
Clinical narrative: Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 15-JUL-2013 (lot # H021608, Expiration Date: 13-AUG-2015). This is one of the report from the same source, linked reports. Additional information is not expected.